Eiry Roberts
Chief Medical Officer at Neurocrine Biosciences Inc (NBIX)
Eiry Roberts has filed 34 insider reports with the SEC since February 2021, as chief Medical Officer at Neurocrine Biosciences Inc (NBIX), director at Bausch Health Companies Inc. (BHC) and director at Amicus Therapeutics, Inc. (FOLD). Eiry Roberts made no open-market purchases or sales in the last 12 months. The latest filing, on November 5, 2026, reports grant or award at Neurocrine Biosciences Inc (NBIX).
- Filings
- 34
- Companies
- 3
- Bought on market
- None
- Sold on market
- $19M
Companies where Eiry Roberts is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| NBIX Neurocrine Biosciences Inc | Chief Medical Officer | 35,640 | $19M | $164.63 | Nov 5, 2026 | ||
| BHC Bausch Health Companies Inc. | Directorsince May 2026 | 45,871 | $8.18 | May 26, 2026 | |||
| FOLD Amicus Therapeutics, Inc. | Directorsince June 2021 | 0 | Apr 27, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 4, 2026NBIXChief Medical Officer Roberts Eiry was granted 8,314 stock options and was granted 1,506 restricted stock unitsForm 4Grant or award
- May 22, 2026BHCDirector Roberts Eiry was granted 45,871 sharesForm 4Grant or award
- May 19, 2026BHCEiry Roberts became an insiderForm 3New insider
- Apr 27, 2026FOLDDirector Roberts Eiry returned $1,105,988 worth of shares to the company (76,275 units at $14.50), closing all direct ownership in the companyForm 4Sale back to the company
- Jun 5, 2025FOLDDirector Roberts Eiry was granted 20,414 shares, increasing direct ownership by 37% to 76,275 unitsForm 4Grant or award
- Feb 14, 2025-$258KNBIXChief Medical Officer Roberts Eiry converted options into 4,605 shares and sold $258,264 worth of shares (2,218 units at $116.44), increasing direct ownership by 7% to 35,640 unitsForm 4Grant or awardExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 13, 2025~$131KNBIXEiry Roberts plans to sell 1,114 shares (~$131K)Form 144Planned sale10b5-1 plan
- Feb 10, 2025-$116KNBIXChief Medical Officer Roberts Eiry converted options into 1,860 shares and sold $115,853 worth of shares (980 units at $118.22), increasing direct ownership by 3% to 33,253 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jan 31, 2025-$223KNBIXChief Medical Officer Roberts Eiry converted options into 2,769 shares and sold $222,636 worth of shares (1,457 units at $152.80), increasing direct ownership by 4% to 32,373 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 17, 2024NBIXSEC Form 4 filed by Chief Medical Officer Roberts EiryForm 4Grant or award
- Nov 8, 2024NBIXChief Medical Officer Roberts Eiry exercised 7,345 shares at a strike of $81.67, increasing direct ownership by 31% to 31,061 unitsForm 4Exercise or conversion of a derivative
- Jun 6, 2024FOLDRoberts Eiry was granted 11,847 shares, increasing direct ownership by 27% to 55,861 unitsForm 4Grant or award
- Feb 13, 2024-$148KNBIXRoberts Eiry sold $148,122 worth of shares (1,114 units at $132.96), decreasing direct ownership by 4% to 23,716 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Feb 8, 2024-$291KNBIXRoberts Eiry sold $290,968 worth of shares (2,101 units at $138.49), decreasing direct ownership by 1% to 22,717 unitsForm 4Open-market sale10b5-1 plan
- Jan 31, 2024-$205KNBIXRoberts Eiry sold $205,132 worth of shares (1,457 units at $140.79), decreasing direct ownership by 7% to 20,832 unitsForm 4Open-market sale10b5-1 plan
- Dec 22, 2023-$1.27MNBIXRoberts Eiry sold $1,267,448 worth of shares (10,000 units at $126.74), decreasing direct ownership by 34% to 19,521 unitsForm 4Open-market sale10b5-1 plan
- Dec 12, 2023-$1.68MNBIXRoberts Eiry exercised 13,925 shares at a strike of $81.05 and sold $1,675,240 worth of shares (13,925 units at $120.30)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 8, 2023-$9.35MNBIXRoberts Eiry exercised 77,679 shares at a strike of $78.53 and sold $9,350,350 worth of shares (77,679 units at $120.37)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 6, 2023-$1.01MNBIXRoberts Eiry exercised 8,396 shares at a strike of $77.81 and sold $1,007,780 worth of shares (8,396 units at $120.03)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 21, 2023-$343KNBIXSEC Form 4: Roberts Eiry sold $343,388 worth of shares (3,198 units at $107.38), decreasing direct ownership by 10% to 29,521 unitsForm 4Open-market sale10b5-1 plan
- Jun 8, 2023FOLDSEC Form 4 filed by Roberts EiryForm 4Grant or award
- Apr 24, 2023-$1.49MNBIXSEC Form 4 filed by Roberts EiryForm 4Open-market sale10b5-1 plan
- Apr 27, 2023NBIXSEC Form 4 filed by Roberts Eiry (Amendment)Form 4
- Feb 13, 2023NBIXSEC Form 4 filed by Roberts EiryForm 4Grant or award
- Feb 8, 2023-$1.7MNBIXSEC Form 4: Roberts Eiry sold $1,697,707 worth of shares (16,525 units at $102.74) as part of a pre-agreed trading plan, increasing direct ownership by 45% to 41,015 units to cover taxesForm 4Open-market sale10b5-1 plan
- Jan 31, 2023-$160KNBIXSEC Form 4: Roberts Eiry sold $160,254 worth of shares (1,457 units at $109.99) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 26,171 units (withholding tax)Form 4Open-market sale10b5-1 plan
- Jun 9, 2022FOLDSEC Form 4: Roberts Eiry was granted 12,671 shares, increasing direct ownership by 56% to 35,430 unitsForm 4Grant or award
- Feb 8, 2022-$300KNBIXSEC Form 4: Roberts Eiry sold $299,590 worth of shares (3,724 units at $80.45) as part of a pre-agreed trading plan, increasing direct ownership by 1% to 24,625 units (for withholding tax)Form 4Open-market sale10b5-1 plan
- Jan 31, 2022NBIXSEC Form 4 filed by Roberts EiryForm 4Grant or award
- Jan 10, 2022-$196KNBIXSEC Form 4: Roberts Eiry sold $196,088 worth of shares (2,632 units at $74.50) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 21,279 units to satisfy withholding obligationForm 4Open-market sale10b5-1 plan
- Jun 10, 2021FOLDSEC Form 4: ROBERTS EIRY was granted 22,759 units of Common StockForm 4Grant or award
- Jun 10, 2021FOLDSEC Form 3 filed by ROBERTS EIRYForm 3New insider
- Feb 8, 2021NBIXSEC Form 4 filed by Eiry RobertsForm 4Grant or award
- Feb 8, 2021-$276KNBIXSEC Form 4: Eiry Roberts sold $275,944 worth of Common Stock (2,363 units at $116.78), increasing ownership by 4% to 18,693 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
Compare Eiry Roberts with
- Eiry Roberts vs George J Morrow1 shared
- Eiry Roberts vs Kyle Gano1 shared
- Eiry Roberts vs John Paulson1 shared
- Eiry Roberts vs Sandra Leung1 shared
- Eiry Roberts vs Amy B Wechsler1 shared
- Eiry Roberts vs Jude Onyia1 shared
Other insiders at the same companies
- George J MorrowNBIX
- Kyle GanoNBIX
- John PaulsonBHC
- Sandra LeungBHC
- Amy B WechslerBHC
- Jude OnyiaNBIX
- Darin LippoldtNBIX
- Sanjay Chandru KeswaniNBIX
- Kevin Charles GormanNBIX
- Ingrid DelaetNBIX
- Julie CookeNBIX
- David W. BoyerNBIX
- Eric BenevichNBIX
- Matt AbernethyNBIX
- Stephen A SherwinNBIX
- Aimee J. LenarBHC
Questions about Eiry Roberts
- What is Eiry Roberts's role at Neurocrine Biosciences Inc?
- Eiry Roberts reports to the SEC as chief Medical Officer at Neurocrine Biosciences Inc (NBIX), according to the latest filing on November 5, 2026. Eiry Roberts has also filed as director at Bausch Health Companies Inc. (BHC) and director at Amicus Therapeutics, Inc. (FOLD).
- How many shares does Eiry Roberts own?
- After the latest filing that states it, Eiry Roberts directly owned 35,640 shares of Neurocrine Biosciences Inc (NBIX) and 45,871 shares of Bausch Health Companies Inc. (BHC). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Eiry Roberts bought or sold stock recently?
- The most recent open-market sale was on February 14, 2025: sold 2,218 shares of Neurocrine Biosciences Inc (NBIX) for $258K at an average of $116.44.
- How do I get alerts when Eiry Roberts files?
- Follow Eiry Roberts on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Eiry Roberts filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Eiry Roberts (SEC CIK 0001727606). Totals count each trade once, skipping amendments whose original is on file, from Feb 10, 2021 on. View on SEC EDGAR